[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.4014/jmb.1412.12023

Anti-Mycobacterial Activity of Tamoxifen Against Drug-Resistant and Intra-Macrophage Mycobacterium tuberculosis

Jang, Woong Sik (Regional Innovation Center, Soonchunhyang University)
Kim, Sukyung (Department of Microbiology and Immunology, School of Medicine, Soonchunhyang University)
Podder, Biswajit (Department of Microbiology and Immunology, School of Medicine, Soonchunhyang University)
Jyoti, Md. Anirban (Department of Microbiology and Immunology, School of Medicine, Soonchunhyang University)
Nam, Kung-Woo (Departments of Life Science and Biotechnology)
Lee, Byung-Eui (Chemistry, Soonchunhyang University)
Song, Ho-Yeon (Regional Innovation Center, Soonchunhyang University)

Publication Information

Journal of Microbiology and Biotechnology / v.25, no.6, 2015 , pp. 946-950 More about this Journal

Abstract

Recently, it has become a struggle to treat tuberculosis with the current commercial antituberculosis drugs because of the increasing emergence of multidrug-resistant (MDR) tuberculosis and extensively drug-resistant (XDR) tuberculosis. We evaluated here the antimycobacterial activity of tamoxifen, known as a synthetic anti-estrogen, against eight drugsensitive or resistant strains of Mycobacterium tuberculosis (TB), and the active intracellular killing of tamoxifen on TB in macrophages. The results showed that tamoxifen had antituberculosis activity against drug-sensitive strains (MIC, 3.125-6.25 µg/ml) as well as drugresistant strains (MIC, 6.25 to 12.5 µg/ml). In addition, tamoxifen profoundly decreased the number of intracellular TB in macrophages in a dose-dependent manner.

Keywords

Mycobacterium tuberculosis; tamoxifen; intracellular killing; MDR; XDR;

Citations & Related Records

Reference

1	Singh R, Hussain S, Verma R, Sharma P. 2013. Antimycobacterial screening of five Indian medicinal plants and partial purification of active extracts of Cassia sophera and Urtica dioica. Asian Pac. J. Trop. Med. 6: 366-371. DOI ScienceOn
2	Naik SK, Mohanty S, Padhi A, Pati R, Sonawane A. 2014. Evaluation of antibacterial and cytotoxic activity of Artemisia nilagirica and Murraya koenigii leaf extracts against mycobacteria and macrophages. BMC Complement. Altern. Med. 14: 87. DOI ScienceOn
3	Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F. 2002. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46: 2720-2722. DOI
4	Pecora ND, Fulton SA, Reba SM, Drage MG, Simmons DP, Urankar-Nagy NJ, et al. 2009. Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection. Cell Immunol. 254: 94-104. DOI ScienceOn
5	Vandal OH, Nathan CF, Ehrt S. 2009. Acid resistance in Mycobacterium tuberculosis. J. Bacteriol. 191: 4714-4721. DOI ScienceOn
6	Vandal OH, Pierini LM, Schnappinger D, Nathan CF, Ehrt S. 2008. A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nat. Med. 14: 849-854. DOI ScienceOn
7	Jayachandran R, Scherr N, Pieters J. 2012. Elimination of intracellularly residing Mycobacterium tuberculosis through targeting of host and bacterial signaling mechanisms. Expert Rev. Anti Infect. Ther. 10: 1007-1022. DOI ScienceOn
8	Christophe T, Jackson M, Jeon HK, Fenistein D, ContrerasDominguez M, Kim J, et al. 2009. High content screening identifies decaprenyl-phosphoribose 2’ epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog. 5: e1000645. DOI ScienceOn
9	Dolan K, Montgomery S, Buchheit B, Didone L, Wellington M, Krysan DJ. 2009. Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization. Antimicrob. Agents Chemother. 53: 3337-3346. DOI
10	El Arbi M, Théolier J, Pigeon P, Jellali K, Trigui F, Top S, et al. 2014. Antibacterial properties and mode of action of new triaryl butene citrate compounds. Eur. J. Med. Chem. 76: 408-413. DOI ScienceOn
11	Miguel DC, Zauli-Nascimento RC, Yokoyama-Yasunaka JK, Katz S, Barbieri CL, Uliana SR. 2009. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections. J. Antimicrob. Chemother. 63: 365-368. DOI ScienceOn
12	Kaufmann SHE. 2001. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1: 20-30. DOI ScienceOn
13	Luxo C, Jurado AS, Madeira VM, Silva MT. 2003. Tamoxifen induces ultrastructural alterations in membranes of Bacillus stearothermophilus. Toxicol. Vitol. 17: 623-628. DOI ScienceOn
14	Luo X, Pires D, Ainsa JA, Gracia B, Mulhovo S, Duarte A, et al. 2011. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique. J. Ethnopharmacol. 137: 114-120. DOI ScienceOn
15	Chen FC, Liao YC, Huang JM, Lin CH, Chen YY, Dou HY, Hsiung CA. 2014. Pros and cons of the tuberculosis drugome approach - an empirical analysis. PLoS One 9: e100829. DOI ScienceOn
16	Atroshi F, Rizzo A, Westermarck T, Ali-Vehmas T. 1998. Effects of tamoxifen, melatonin, coenzyme Q10, and _L-carnitine supplementation on bacterial growth in the presence of mycotoxins. Pharmacol. Res. 38: 289-295. DOI ScienceOn
17	Caleffi-Ferracioli KR, Maltempe FG, Siqueira VL, Cardoso RF. 2013. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method. Tuberculosis (Edinb.) 93: 660-663. DOI ScienceOn
18	Changsen C, Franzblau SG, Palittapongarnpim P. 2003. Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter. Antimicrob. Agents Chemother. 47: 3682-3687. DOI

Reference

11	(2015) Journal of microbiology and biotechnology In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in Mycobacterium tuberculosis / 27 (11) , 1932
None	(2015) Bmc complementary and alternative medicine Thymoquinone (TQ) inhibits the replication of intracellular <I>Mycobacterium tuberculosis</I> in macrophages and modulates nitric oxide production / 17 (None) , 279
4	(2018) Cancer investigation Tamoxifen Never Ceases to Amaze: New Findings on Non-Estrogen Receptor Molecular Targets and Mediated Effects / 36 (4) , 211
11	(2015) Antimicrobial agents and chemotherapy Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169) / 62 (11) , e00840-18
6	(2015) mBio Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease / 9 (6) , e02272-18
None	(2019) Scientific reports Evaluation of in silico designed inhibitors targeting MelF (Rv1936) against Mycobacterium marinum within macrophages / 9 (None) , 10084
1	(2015) Microbial drug resistance : MDR : mechanisms, epidemiology, and disease Finding New Ways to Combat Multidrug-Resistant Tuberculosis / 26 (1) , 71
2	(2020) Current molecular medicine Selective Estrogen Receptor Modulators (SERMs): Mechanistic Insights Against Microbial Infections / 20 (2) , 102
2	(2015) MSphere Bazedoxifene Suppresses Intracellular <I>Mycobacterium tuberculosis</I> Growth by Enhancing Autophagy / 5 (2) , e00124-20
9	(2015) Cells Nuclear Receptors as Autophagy-Based Antimicrobial Therapeutics / 9 (9) , 1979
13	(2015) Future microbiology Selective estrogen receptor modulators against Gram-positive and Gram-negative bacteria: an experimental study / 16 (13) , 987
11	(2021) The journal of microbiology Activity of Lactobacillus crispatus isolated from vaginal microbiota against Mycobacterium tuberculosis / 59 (11) , 1019
None	(2015) Biomedicine & pharmacotherapy ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen / 144 (None) , 112274